Search tips
Search criteria 


Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. 1999 July; 43(7): 1811–1812.

In Vitro Inhibition of the Growth of Helicobacter pylori by Oil-Macerated Garlic Constituents

Helicobacter pylori, a gram-negative curved rod bacterium, is relevant to the disease of gastric and duodenal mucosae, and the H. pylori-infected populations have a high risk of gastric cancer (3). Some epidemiological reports showed that high intake of Allium vegetables including garlic (Allium sativum L.) reduces the risk of gastric cancer (4). Oil maceration is one method for processing garlic, and this type of garlic product is common as health food in Europe. In a previous study, we isolated some antimicrobial compounds from oil-macerated garlic extract (OMGE), and they inhibited gram-positive and -negative bacteria and yeast (6, 810). Sivam et al. (7) have demonstrated the antibacterial effect of crude garlic extracts against H. pylori; however, the antibacterial activity of each garlic constituent against H. pylori has not been reported. Therefore, we attempted to examine the antibacterial effect of OMGE constituents against H. pylori.

An OMGE was prepared according to the method of Yoshida et al. (8, 9). H. pylori strains used are indicated in Table Table1.1. To analyze the anti-H. pylori activity of OMGE, each OMGE constituent was purified. E- and Z-ajoenes (E- and Z-4,5,9-trithiadodeca-1,6,11-triene-9-oxide) (2) and two vinyldithiins (2-vinyl-4H-1,3-dithiin and 3-vinyl-4H-1,2-dithiin) (1) were purified according to the methods described by Block et al. (1, 2), and Z-10-devinylajoene (Z-10-DA; Z-4,5,9-trithiadeca-1,6-diene-9-oxide) (8), iso-E-10-devinylajoene (iso-E-10-DA; E-4,5,9-trithiadeca-1,7-diene-9-oxide) (9), and thiosulfinates (10) were purified according to the methods described by Yoshida et al. (810). Allicin was prepared by the method of Mayeux et al. (5). The MICs of all constituents and several antibiotics were determined as described elsewhere (6, 8), i.e., each preculture containing 103 cells was plated onto solid medium consisting of brain heart infusion agar containing 0.25% yeast extract and 10% fetal bovine serum (Biowhittaker, Wakersville, Md.) with or without various concentrations of the constituents or antibiotics and cultivated under microaerophilic conditions for 5 days. The surviving cells were detected on the plate as colonies, and the MIC was defined as the concentration leaving no survivors. Results are shown in Table Table1.1. The differences in MICs between the three H. pylori strains were not significant. Ajoenes (Z- and E-ajoene, Z-10-DA, and iso-E-10-DA), which are the main constituents of OMGE, showed inhibition of the H. pylori growth at 10 to 25 μg/ml. Two different vinyldithiins did not inhibit H. pylori growth at concentrations of <100 μg/ml. Among the thiosulfinates, 2-propene-1-sulfinothioic acid S-methyl ester [AllS(O)SMe] inhibited H. pylori growth at 20 to 25 μg/ml. However, 2-propene-1-sulfinothioic acid S-(E,Z)-1-propenyl ester [AllS(O)SPn-(E,Z)] did not inhibit H. pylori growth at concentrations of <100 μg/ml. Allicin, which is not an OMGE constituent, inhibited H. pylori growth at 20 to 30 μg/ml. AllS(O)SPn-(E,Z), allicin, and AllS(O)SMe differ with respect to the S-1-alk(en)yl group. In this part of the structure, methyl and allyl groups were effective but the propenyl group was ineffective for H. pylori inhibition.

MICs of OMGE constituents and antibiotics for H. pylori

From these results, it is obvious that the OMGE contained many anti-H. pylori compounds, and their MICs were 10 to 25 μg/ml. These results suggest that OMGE should be tested for efficacy against H. pylori in vivo.


1. Block E, Ahmad S, Catalfamo J L, Jain M K, Apitz-Castro R. Antithrombotic organosulfur compounds from garlic: structural, mechanistic, and synthetic studies. J Am Chem Soc. 1986;108:7045–7055.
2. Block E, Ahmad S, Jain M K, Crecely R W, Apitz-Castro R, Cruz M R. (E,Z)-Ajoene: a potent antithrombotic agent from garlic. J Am Chem Soc. 1984;106:8295–8296.
3. Buiatti E, Muñoz N, Vivas J, Cano E, Peraza S. Difficulty in eradicating Helicobacter pylori in a population at high risk for stomach cancer in Venezuela. Cancer Causes Control. 1994;5:249–254. [PubMed]
4. Buiatti E, Palli D, Decarli A, Amadori D, Avellini C, Bianchi S, Biserni R, Cipriani F, Cocco P, Giacosa A, Marubini E, Puntoni R, Vindigni C, Fraumeni J, Jr, Blot W. A case-control study of gastric cancer and diet in Italy. Int J Cancer. 1989;44:611–616. [PubMed]
5. Mayeux P R, Agrawal K C, Tou J-S H, King B T, Lippton H L, Hyman A L, Kadowitz P J, McNamara D B. The pharmacological effects of allicin, a constituent of garlic oil. Agents Actions. 1988;25:182–190. [PubMed]
6. Naganawa R, Iwata N, Ishikawa K, Fukuda H, Fujino T, Suzuki A. Inhibition of microbial growth by ajoene, a sulfur-containing compound derived from garlic. Appl Environ Microbiol. 1996;62:4238–4242. [PMC free article] [PubMed]
7. Sivam G P, Lampe J W, Ulness B, Swanzy S R, Potter J D. Helicobacter pylori-in vitro susceptibility to garlic (Allium sativum) extract. Nutr Cancer. 1997;27:118–121. [PubMed]
8. Yoshida H, Iwata N, Katsuzaki H, Naganawa R, Ishikawa K, Fukuda H, Fujino T, Suzuki A. Antimicrobial activity of a compound isolated from an oil-macerated garlic extract. Biosci Biotechnol Biochem. 1998;62:1014–1017. [PubMed]
9. Yoshida H, Katsuzaki H, Ohta R, Ishikawa K, Fukuda H, Fujino T, Suzuki A. An organosulfur compound isolated from an oil-macerated garlic extract, and its antimicrobial effect. Biosci Biotechnol Biochem. 1999;63:588–590. [PubMed]
10. Yoshida H, Katsuzaki H, Ohta R, Ishikawa K, Fukuda H, Fujino T, Suzuki A. Antimicrobial activity of the thiosulfinates isolated from an oil-macerated garlic extract. Biosci Biotechnol Biochem. 1999;63:591–594. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)